Abstract:Recent findings have reported that human serum microRNAs (miRNAs) can be used as prognostic biomarkers in various cancers. We aimed to explore the prognostic value of serum miRNAs in nasopharyngeal carcinoma (NPC) patients. The level of serum miRNA was retrospectively analyzed in 512 NPC patients recruited between January 2001 and December 2006. In the discovery stage, a microarray followed by reverse transcription-quantitative polymerase chain reaction was used to identify differentially altered miRNAs in eight patients with shorter survival and eight patients with longer survival who were well matched by age, sex and clinical stage. The identified serum miRNAs were then validated in all 512 samples, which were randomly divided into a training set and a validation set. Four serum miRNAs (miR-22, miR-572, miR-638 and miR-1234) were found to be differentially altered and were used to construct a miRNA signature. Risk scores were calculated to classify the patients into high- or low-risk groups. Patients with high-risk scores had poorer overall survival [hazard ratio (HR), 2.54; 95% confidence interval (CI), 1.57-4.12; p < 0.001] and distant metastasis-free survival (HR, 3.28; 95% CI, 1.82-5.94; p < 0.001) than those with low-risk scores in the training set; these results were confirmed in the validation and combined sets. The miRNA signature and TNM stage were independent prognostic factors. The combination of the miRNA signature and TNM stage had a better prognostic value than the TNM stage or miRNA signature alone. The four-serum miRNA signature may add prognostic value to the TNM staging system and provide information for personalized therapy in NPC.What's new? Short non-coding RNA sequences, or microRNAs, that circulate in serum are easily accessible, promising biomarkers for incorporation into the tumor-node-metastasis (TNM) staging system. This study shows that a four-miRNA signature is able to predict survival in nasopharyngeal carcinoma, serving as an independent prognostic factor. When combined with TNM staging, the miRNA signature boosted the overall prognostic power, improving it over either approach alone. The results also suggest that serum miRNAs may play an important role in nasopharyngeal carcinoma development and progression, in addition to being potential prognostic biomarkers.

Diagnostic and Prognostic Value of Plasma Microrna Deregulation in Nasopharyngeal Carcinoma

Plasma Microrna Profiling in Nasopharyngeal Carcinoma Patients Reveals Mir-548Q and Mir-483-5p As Potentia Lbiomarkers

Profiling Plasma Microrna in Nasopharyngeal Carcinoma with Deep Sequencing.

Plasma Microrna Expression Signature Involving Mir-548Q, Mir-630 and Mir-940 As Biomarkers for Nasopharyngeal Carcinoma Detection.

Circulating Mir-17, Mir-20a, Mir-29c, And Mir-223 Combined As Non-Invasive Biomarkers In Nasopharyngeal Carcinoma

Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.

Plasma Epstein-Barr virus microRNA BART8-3p as a potential biomarker for detection and prognostic prediction in early nasopharyngeal carcinoma

Combination of Plasma Micrornas with Serum Ca19-9 for Early Detection of Pancreatic Cancer

Screening of Key Mirnas and Evaluation of Their Diagnostic and Prognostic Values in Nasopharyngeal Carcinoma.

Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma

Identification of markers for predicting prognosis and endocrine metabolism in nasopharyngeal carcinoma by miRNA-mRNA network mining and machine learning

Circulating MicroRNA Panel As a Diagnostic Marker for Hepatocellular Carcinoma

Genome-wide Study of Salivary Micrornas As Potential Noninvasive Biomarkers for Detection of Nasopharyngeal Carcinoma

Tumor-Educated Platelet miR-18a-3p as a Novel Liquid-Biopsy Biomarker for Early Diagnosis and Chemotherapy Efficacy Monitoring in Nasopharyngeal Carcinoma

Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma

A Four-Mirna Signature Identified From Genome-Wide Serum Mirna Profiling Predicts Survival In Patients With Nasopharyngeal Carcinoma

A novel three-microRNA signature for predicting survival in patients with nasopharyngeal carcinoma

Upregulation of Circulating Mir-21 is Associated with Poor Prognosis of Nasopharyngeal Carcinoma.

Microrna Expression Profiling of Nasopharyngeal Carcinoma.

The Role of Plasma Mirnas in the Diagnosis of Pulmonary Nodules

A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis